GSK: Depemokimab Monoclonal Antibody Reduces Asthma Attacks
Depemokimab was shown to reduce exacerbations in patients with severe asthma. The proportions of adverse events of Depemokimab and the ...
Depemokimab was shown to reduce exacerbations in patients with severe asthma. The proportions of adverse events of Depemokimab and the ...
3-day free trial · cancel anytime
Then $4.99/month. Manage renewal in your account.
NPI Lookup · Free
Search by name or NPI number, live from the CMS NPI Registry.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
Monthly plan selected: $4.99 /month.
3-day free trial · cancel anytime
Then $4.99/month. Manage renewal in your account.
Yearly plan selected: $49.90 /year.
2 months free
Then $49.90/year.
Already a member? Sign in